Skip to content
Home/Companies/Healthcare/BiOligo Biotechnology
BB

BiOligo Biotechnology

Healthcare·US·Active

BiOligo Biotechnology is a healthcare company, headquartered in USA.

Entry
–
Hold
–
Status
Active
Est. EV
–

Who owns BiOligo Biotechnology?

BiOligo Biotechnology is currently owned by The Carlyle Group.

Hand-verified · updated 2026-04-21

The Carlyle Group
Investor
The Carlyle Group
Fund attribution unclassified.

Key facts

HQUSA
SectorHealthcare

More from The Carlyle Group Portfolio

Other portfolio companies in the same fund.

Adicon Holdings Limited
Active
HealthcareUS
AGILOX Systems GmbH
Active
IndustrialsGermany
Alamar Foods
Exited 2022
ConsumerSaudi Arabia
Ampere Computing Holdings LLC
Active
TMTUS
Ant Financial
Active
FinancialsChina
China Literature Limited
Exited 2017
TMTChina

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
A Place for Mom
Active
Silver LakeUS
Abode Healthcare
Active
Summit PartnersUS
AccentCare
Active
Advent InternationalUS
Acusurgical
Active
Supernova InvestFrance
Adagene
Active
General AtlanticChina
Data refreshed weekly · Sourced from public filings